About Unison Pharmaceuticals Private Limited
Data last updated:
Unison Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2001PTC079092. Its GSTIN is 24AABCU6937A2ZK (Gujarat). The company holds 6 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹8.81 Cr. It was formerly known as Unison Pharmaceutical Private Limited. It is led by directors Bhagyesh Nitinbhai Shah (Managing Director) and Nitin Rasiklal Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unison House Nr. Prernatirth Derasar Nr. Ratnadeep – II Satellite Jodhpur, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹537.1 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹92.38 Cr (net margin 17.2%) and EBITDA of ₹146.46 Cr (EBITDA margin 27.3%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 22% over five years.
The company has about 1,434 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Unison Pharmaceuticals. As per MCA filings, the company has open charges of ₹300.59 Cr on record. Court records list 25 cases involving the company, including 19 filed by the company and 6 filed against it; 5 cases are pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹38.5 Cr; the latest was in August 2024. Its 7 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Shalina Laboratories Private Limited with revenue of ₹551.12 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unisonpharmaceuticals.com.
Company details
CIN history
Unison Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232HP2001PTC024442. The current CIN is U24232GJ2001PTC079092, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232GJ2001PTC079092 | Current |
| U24232HP2001PTC024442 | Previous |
Contact details
Unison Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is unisonpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnison House Nr. Prernatirth Derasar Nr. Ratnadeep – II Satellite Jodhpur, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Unison Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Unison Pharmaceuticals operates one associated brand: Unison Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical products for health needs and supplies across India. | unisonpharmaceuticals.com |
Business activity
The main business activity of Unison Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Unison Pharmaceuticals Private Limited, buy the company report.
Financials of Unison Pharmaceuticals Private Limited
FY 2024 filings availableUnison Pharmaceuticals Private Limited reported revenue of ₹537.1 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 23% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹146.46 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹92.38 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.3% | ||||
| Net Profit Margin | 17.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unison Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unison Pharmaceuticals Private Limited
Unison Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhagyesh Nitinbhai Shah Also directs: Unisons Suppercare Hospitals Private Limited, Recube Enviro Private Limited, Unison Wellness Private Limited and 5 more | Managing Director | 27 Oct 2013 | 12 Years 11 Months | Current |
| Nitin Rasiklal Shah Also directs: Unisons Suppercare Hospitals Private Limited, Recube Enviro Private Limited, Unison Wellness Private Limited and 5 more | Director | 27 Oct 2013 | 12 Years 11 Months | Current |
Peer comparison
Unison Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shalina Laboratories Private Limited | ₹551.12 Cr (FY 2023) | -1.0% | Mumbai, Maharashtra, India | |||
| German Remedies Pharmaceuticals Private Limited | ₹546.98 Cr (FY 2025) | 9.0% | Ahmedabad, Gujarat, India | |||
| Graviti Pharmaceuticals Private Limited | ₹543.75 Cr (FY 2025) | 17.0% | Hyderabad, Telangana, India | |||
| Kusum Healthcare Private Limited | ₹537.89 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India | |||
| Unison Pharmaceuticals Private Limitedthis company | ₹537.1 Cr (FY 2025) | ₹92.38 Cr | 17.2% | 23.0% | 1,434 | Ahmedabad, Gujarat, India |
| Maneesh Pharmaceuticals Limited | ₹534.48 Cr (FY 2022) | 28.0% | Mumbai, Maharashtra, India | |||
| Mapaex Health and Personalcare Private Limited | ₹514.15 Cr (FY 2024) | 23.0% | Bhopal, Madhya Pradesh, India | |||
| Flamingo Pharmaceuticals Limited | ₹508.5 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Unison Pharmaceuticals Private Limited, buy the company report.
Auditor
Unison Pharmaceuticals Private Limited is audited by APT & CO. LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| APT & CO. LLP | FY 2024 | 014621C |
Shareholding
The shareholding of Unison Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unison Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jul 2025 | 101133408 | Hdfc Bank Limited | ₹1.94 Cr | Open | |
| 27 Aug 2020 | 100372279 | Hdfc Bank Limited | ₹29 Lakh | Open | |
| 03 Aug 2015 | 10584059 | Hdfc Bank Limited | ₹149.18 Cr | Open | |
| 31 Jul 2015 | 10584060 | Hdfc Bank Limited | ₹149.18 Cr | Open |
To see the full charge records of Unison Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Unison Pharmaceuticals Private Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹38.5 Cr; the latest was in August 2024.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2024 | Secondary share transfer | Undisclosed | Seller: 2 individuals |
| Nov 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2014 | Funding round | ₹38.5 Cr | Investors: an individual |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Unison Pharmaceuticals Private Limited has 25 court cases on record: 19 filed by Unison Pharmaceuticals, 6 filed against it. 5 cases are pending and 20 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 1 | 2 |
| High courts | 10 | 2 | 1 |
| Supreme Court | 2 | 1 | 0 |
| NCLAT | 2 | 2 | 2 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Appeal | Filed by the company against N Line Healthcare Private Limited and 4 others | Pending |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed by the company against Greatlee Pharmaceuticals Pvt Ltd and 1 other | Disposed |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed by the company against N Line Healthcare Private Limited and 2 others | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed by the company against Univentis Medicare Limited and 1 other | Disposed |
| District court, Ahmedabad, Gujarat | Court case (TMSUIT) | Filed against the company by Novartis Healthcare Pvt Limited and 1 other | Disposed |
To see the full case history of Unison Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unison Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Unison Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Unison Remedies Private Limited | U24230GJ2012PTC072070 |
To see the full group structure of Unison Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Unison Pharmaceuticals Private Limited has a workforce of 1,434 employees on its EPFO records as of Dec 07, 2025, across 2 active EPFO establishments.
GST
Unison Pharmaceuticals has 6 GST registrations: 5 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCU6937A2ZK | Gujarat | Active | 01 Jul 2017 |
| 24AABCU6937A3ZJ | Gujarat | Active | 01 Mar 2025 |
| 23AABCU6937A1ZN | Madhya Pradesh | Active | 09 Nov 2020 |
| 29AABCU6937A1ZB | Karnataka | Active | 24 Aug 2021 |
To see the full GST registrations and return filing status of Unison Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unison Pharmaceuticals Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Bhagyesh Nitinbhai Shah ceased to be Director on 30 Sep 2014.
2 earlier events are in the company report.
Frequently asked questions
Unison Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 June 2001 (25+ years old) and is registered under CIN U24232GJ2001PTC079092.
Unison Pharmaceuticals has 2 current directors:
- Bhagyesh Nitinbhai Shah - Managing Director
- Nitin Rasiklal Shah - Director
The latest financial statements of Unison Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Unison Pharmaceuticals is 24AABCU6937A2ZK, registered in Gujarat. The company has 6 GST registrations in all, of which 5 are active and 1 is cancelled or inactive. Other active GSTINs include 24AABCU6937A3ZJ (Gujarat), 23AABCU6937A1ZN (Madhya Pradesh), 29AABCU6937A1ZB (Karnataka).
The CIN (Corporate Identification Number) of Unison Pharmaceuticals is U24232GJ2001PTC079092. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unison Pharmaceuticals has 25 court cases on record: 19 filed by the company and 6 filed against it. 5 are pending. Most are in the district courts.
Unison Pharmaceuticals was incorporated on 01 June 2001, making it 25+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Unison Pharmaceuticals has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹38.5 Cr; the latest was in August 2024.
The peers of Unison Pharmaceuticals by revenue are Shalina Laboratories Private Limited, German Remedies Pharmaceuticals Private Limited, Graviti Pharmaceuticals Private Limited, Kusum Healthcare Private Limited, Maneesh Pharmaceuticals Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhagyesh Nitinbhai Shah ceased to be Director on 30 Sep 2014. Rakesh Kumar Bhardwaj ceased to be Director on 12 Nov 2013. Sanjay Saxena ceased to be Director on 12 Nov 2013. Unison Pharmaceuticals has 5 board changes on record in total.
Unison Pharmaceuticals can be reached through the website unisonpharmaceuticals.com. Its registered office is in Ahmedabad, Gujarat, India.